ArticleAmerican journal of nuclear medicine and molecular imaging2013

Peptide receptor radionuclide therapy of treatment-refractory metastatic thyroid cancer using (90)Yttrium and (177)Lutetium labeled somatostatin analogs: toxicity, response and survival analysis.

Hendra Budiawan et al.PubMed ↗Full text ↗

No numbers read from the abstract.